Micro Interventional Devices, Inc.
PrivateLast Round
Series D
Mar 7, 2019
Total Funding Raised
$23.5M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Micro Interventional Devices, Inc. operates in Healthcare & Life Sciences and is based in Newtown, Pennsylvania. Its latest recorded funding round was a Series D round in March 2019.
Micro Interventional Devices, Inc. is a medical device company that designs, manufactures, and commercializes percutaneous solutions for structural heart disease, including transcatheter cardiac repair technologies.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Micro Interventional Devices, Inc. Comparables
Compare Micro Interventional Devices, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| CroíValve | 86% | |
| Valcare Medical | 85% | |
| TRiCares | 84% |
For institutional investors. Book with your work email.
Micro Interventional Devices, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | Mar 7, 2019 | ||||
| Series B | Jan 14, 2013 | ||||
| VC Round | Aug 6, 2012 | ||||
| VC Round | May 9, 2012 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Micro Interventional Devices, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Benjamin Franklin Technology Partners | VC Round, Series D |
| Life Sciences Greenhouse Investments | VC Round |
| Originate Ventures | Series D, Series B |
| Battelle Ventures | VC Round, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 170% MoM.
- May 3, 2025
Monthly visitors increased 61% MoM, reaching 1.5K.
For institutional investors. Book with your work email.
Micro Interventional Devices, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Micro Interventional Devices, Inc.'s valuation, stock price, and market status.
Is Micro Interventional Devices, Inc. a public or private company?
Micro Interventional Devices, Inc. is a private company.
What is the current stock price of Micro Interventional Devices, Inc.?
Micro Interventional Devices, Inc. is a private company, so its shares have no public market price. Caplight tracks Micro Interventional Devices, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Micro Interventional Devices, Inc. worth (valuation)?
Valuation information for Micro Interventional Devices, Inc. is not publicly available.
Can I buy Micro Interventional Devices, Inc. stock?
Micro Interventional Devices, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Micro Interventional Devices, Inc.'s last funding round?
Micro Interventional Devices, Inc.'s most recent funding round was Series D on March 7, 2019.
Who are the main investors in Micro Interventional Devices, Inc.?
Key investors in Micro Interventional Devices, Inc. include Originate Ventures.
Will Micro Interventional Devices, Inc. IPO soon?
No public IPO plans have been announced for Micro Interventional Devices, Inc..
How can I track Micro Interventional Devices, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Micro Interventional Devices, Inc.'s shares on secondary markets.